Tech Company Financing Transactions
Prologue Medicines Funding Round
Prologue Medicines closed a $50 million funding round on 5/7/2024. Investors included Flagship Pioneering.
Transaction Overview
Company Name
Announced On
5/7/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its Decoding Evolutionary Logic of Variant Ensembles (DELVE)� Platform to develop a pipeline of medicines for a wide range of diseases, with an initial focus in immunological, oncology and metabolic indications.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
At Prologue, we are going beyond the human proteome to uncover proteins that have been evolved by viruses with the potential to modulate human physiology and achieve outcomes that human proteins, even designed proteins, cannot. By co-opting viral evolution, we can discover novel proteins with enhanced properties that expand the functional boundaries of proteins encoded by our own genome and learn their design rules to create programmable medicines with desirable features.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lovisa Afzelius
Chief Scientific Officer
Hozefa Bandukwala
President
Theonie Anastassiadis
Vice President
Nirmal Keshava
Vice President
Angela Norton
Vice President
Rakesh Verma
Browse more venture capital transactions:
Prev: 5/7/2024: DwellFi venture capital transaction
Next: 5/7/2024: Think Bioscience venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs